hTR is generally expressed at low levels in normal cells and is substantially up-regulated in cancer cells as shown both by fluorescence in situ studies of a wide range of tumor samples [213] and by tumor specific expression of hTR promoter-driven transgenes in the setting of gene therapy studies [214], [215]. The gene discussed is TERC; the disease is cancer.